Nanoparticles in an antibiotic-loaded nanomesh for drug delivery.
Journal
RSC advances
ISSN: 2046-2069
Titre abrégé: RSC Adv
Pays: England
ID NLM: 101581657
Informations de publication
Date de publication:
23 Sep 2019
23 Sep 2019
Historique:
received:
16
08
2019
accepted:
16
09
2019
entrez:
9
5
2022
pubmed:
24
9
2019
medline:
24
9
2019
Statut:
epublish
Résumé
Antibiotic loaded nanomeshes were fabricated by electrospinning polycaprolactone, a biocompatible polymer, with 12.5% w/w Colistin, 1.4% w/w Vancomycin and either cationic or anionic gold nanoparticles in varying combinations. The resulting nanomeshes had different antibiotic release profiles, with citrate capped gold nanoparticles combined with Colistin having the highest sustained release over 14 days for a 4 mg, 1.5 cm
Identifiants
pubmed: 35530227
doi: 10.1039/c9ra06398f
pii: c9ra06398f
pmc: PMC9072143
doi:
Types de publication
Journal Article
Langues
eng
Pagination
30064-30070Informations de copyright
This journal is © The Royal Society of Chemistry.
Déclaration de conflit d'intérêts
There are no conflicts to declare.
Références
J Colloid Interface Sci. 2018 Dec 15;532:12-23
pubmed: 30077062
Crit Care. 2003 Oct;7(5):R78-83
pubmed: 12974973
Nanomaterials (Basel). 2016 Dec 29;7(1):
pubmed: 28336838
Bioengineering (Basel). 2018 Jan 27;5(1):
pubmed: 29382065
JAMA. 2014 Oct 1;312(13):1330-41
pubmed: 25268440
Antimicrob Agents Chemother. 2006 Jun;50(6):1953-8
pubmed: 16723551
Clin Microbiol Rev. 2017 Apr;30(2):557-596
pubmed: 28275006
Iran J Pharm Res. 2015 Summer;14(3):677-91
pubmed: 26330856
Curr Drug Deliv. 2018;15(10):1360-1374
pubmed: 30033869
J Antimicrob Chemother. 2018 Jun 1;73(6):1460-1463
pubmed: 29481657
AAPS PharmSciTech. 2006 Apr 07;7(2):E33
pubmed: 16796351
ACS Nano. 2014 Oct 28;8(10):10682-6
pubmed: 25232643
Polymers (Basel). 2018 Dec 03;10(12):
pubmed: 30961261
Polymers (Basel). 2018 Feb 26;10(3):
pubmed: 30966266
Materials (Basel). 2018 Jun 22;11(7):
pubmed: 29932127
Colloids Surf B Biointerfaces. 2018 Jan 1;161:488-496
pubmed: 29128835
J Nanobiotechnology. 2012 May 06;10:19
pubmed: 22559747
ACS Appl Mater Interfaces. 2019 Apr 3;11(13):12880-12889
pubmed: 30869859
Chem Biol Interact. 2018 Oct 1;294:56-64
pubmed: 30138604
Antimicrob Agents Chemother. 2006 Sep;50(9):2946-50
pubmed: 16940086
Int J Pharm. 2005 Nov 4;304(1-2):91-101
pubmed: 16154302
Eur J Clin Microbiol Infect Dis. 1989 Nov;8(11):943-50
pubmed: 2532132
Crit Care. 2017 Aug 14;21(1):211
pubmed: 28807042
Acta Pharm. 2011 Mar;61(1):25-36
pubmed: 21406341
ACS Appl Mater Interfaces. 2015 Sep 30;7(38):21170-81
pubmed: 26355766
Acta Biomater. 2017 Dec;64:126-136
pubmed: 29030303
Carbohydr Polym. 2019 Feb 1;205:55-62
pubmed: 30446139
J Antimicrob Chemother. 1984 Dec;14 Suppl D:7-18
pubmed: 6440886
Chem Sci. 2015 Sep 1;6(9):5186-5196
pubmed: 29449924
Ther Adv Drug Saf. 2014 Dec;5(6):229-41
pubmed: 25436105
J Intensive Care. 2015 Jan 22;3(1):3
pubmed: 25705428
Eur J Pharm Sci. 2009 Jun 28;37(3-4):249-56
pubmed: 19491012
Curr Med Res Opin. 2015 Apr;31(4):707-21
pubmed: 25697677
J Infect. 2014 Jul;69(1):1-12
pubmed: 24631777